Concussion Market is driven by increasing incidence of head injuries in sports
The concussion market comprises products and equipment designed to detect, diagnose, and treat mild traumatic brain injuries. Some key products in the market include brain injury screening solutions, depth of consciousness monitoring devices, head impact sensors, and other neuro-monitoring equipment. Concussions often occur due to head impact in contact sports and result in short-term impaired brain function. Early detection and management of concussions are crucial to prevent long term health complications. Increasing participation in sports and recreational activities has led to high incidence rates of concussions, driving demand for relevant diagnostic and monitoring solutions in the market.
The global concussion market is estimated to be valued at USD 6.82 Bn in 2024 and is expected to reach USD 10.20 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.
Key Takeaways
Key players operating in the Concussion Market are Nihon Kohden Corporation, Integra LifeSciences, Compumedics Limited, BioDirection (NanoDx), Oculogica, Abbott Laboratories, BrainScope Company Inc., Magstim, BIOMÉRIEUX S.A., Advanced Brain Monitoring, Inc., Healius Limited, Siemens Healthineers, GE Healthcare, Philips Healthcare, and Medtronic plc.
The growing participation in sports and other recreational activities has increased the risk of head injuries. As a result, th
The concussion market comprises products and equipment designed to detect, diagnose, and treat mild traumatic brain injuries. Some key products in the market include brain injury screening solutions, depth of consciousness monitoring devices, head impact sensors, and other neuro-monitoring equipment. Concussions often occur due to head impact in contact sports and result in short-term impaired brain function. Early detection and management of concussions are crucial to prevent long term health complications. Increasing participation in sports and recreational activities has led to high incidence rates of concussions, driving demand for relevant diagnostic and monitoring solutions in the market.
The global concussion market is estimated to be valued at USD 6.82 Bn in 2024 and is expected to reach USD 10.20 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.
Key Takeaways
Key players operating in the Concussion Market are Nihon Kohden Corporation, Integra LifeSciences, Compumedics Limited, BioDirection (NanoDx), Oculogica, Abbott Laboratories, BrainScope Company Inc., Magstim, BIOMÉRIEUX S.A., Advanced Brain Monitoring, Inc., Healius Limited, Siemens Healthineers, GE Healthcare, Philips Healthcare, and Medtronic plc.
The growing participation in sports and other recreational activities has increased the risk of head injuries. As a result, th
6 days ago
